🇺🇸

US SEC Filing Intelligence

· daily

US Corporate Board Director Changes SEC Filings — September 25, 2026

This digest of 36 SEC filings reveals a period of significant leadership transition across US equities, with 10 officer changes (CEO, CFO, COO) and 12 board appointments/resignations concentrated in the week of September 25, 2026. Key themes include orderly CEO successions at AllianceBernstein and CoreCivic, a wave of COO departures across BlackRock's credit funds and BitGo, and a notable cluster of board appointments adding deep operational and technology expertise (e.g., FactSet, Duke Energy, Cencora). While most changes are routine, the departures of Monster Beverage's Americas CEO to Coca-Cola and Nextdoor's President of Products signal strategic shifts. Financially, Worthington Enterprises reported strong 13% YoY sales growth and accelerating data center demand, while Janus International's restructuring ($10.8M savings) and Mosaic's new EVP hire indicate operational focus. The overall sentiment is neutral-to-positive, with no major bearish signals from insider activity or guidance cuts, but the high volume of C-suite changes warrants monitoring for execution risk.

36 high priority 36 total filings
· daily

USA Insider Trading Pulse — September 25, 2026

The September 25, 2026 insider trading pulse reveals a predominantly cautious sentiment among corporate insiders, with 10 notable sell transactions totaling over $14 million, including a massive $10.5M sale by a major Redwire Corp shareholder and a $1.5M sale by Credo Technology Group's CTO. However, insider buying is virtually absent, with only one small $6.6K purchase by a Phio Pharmaceuticals director, signaling a lack of conviction in near-term upside. The data shows a strong pattern of pre-planned 10b5-1 sales at high valuations, particularly in the technology and biotech sectors, while energy and industrial companies exhibit routine tax-withholding dispositions. A notable capital allocation trend emerges at Magnolia Oil & Gas, where executives received substantial equity awards alongside tax withholdings, suggesting a focus on long-term incentive alignment. The absence of forward-looking guidance changes or scheduled events in the filings limits catalyst visibility, but the high volume of insider selling at elevated prices (e.g., Twist Bioscience at $175, Semtech at $172) warrants close monitoring for potential sector rotation.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — September 25, 2026

The US SPAC M&A landscape is showing clear signs of stress and execution risk, with 3 out of 4 filings revealing material delays, regulatory non-compliance, or repeated amendments. NMP Acquisition Corp. and Blue Acquisition Corp. both disclosed extensions to their business combination deadlines, indicating that target companies are struggling to deliver audited financials, a critical de-SPAC hurdle. Future Money Acquisition Corp. received a Nasdaq deficiency notice for late filing, adding delisting risk to its timeline. In contrast, Pinnacle Acquisition Corp. is in a clean, early-stage position post-IPO, actively searching for targets in specialty finance. The aggregate picture suggests a bifurcated market: well-capitalized, newly-listed SPACs are proceeding normally, while older, pre-merger SPACs face mounting operational and regulatory pressures. No period-over-period financial trends (revenue, margins) are available as these are procedural filings without operational data.

4 high priority 4 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 25, 2026

The overnight filing batch (Sep 24-25, 2026) reveals a market dominated by capital markets activity, with several SPAC business combinations and de-SPAC transactions progressing, alongside notable insider selling and a few strategic insider purchases. Key themes include significant insider selling in small/mid-cap names (Aspen Aerogels, Mineralys Therapeutics, Omeros) and a major block trade exit by Wood River Capital from Aspen Aerogels, signaling potential sector rotation or liquidity needs. On the positive side, several companies are executing strategic pivots into high-growth sectors like space infrastructure (Non Invasive Monitoring Systems/Gravitics) and autonomous drones (Elroy Air), while others are strengthening governance (BOXABL, Clover Health). Capital allocation trends show a mix of aggressive buybacks (Lloyds Banking Group completing a £1.75B program) and dilutive financing (Black Hawk Acquisition's $200M SEPA). The period-over-period data is limited in this batch, but forward-looking statements and insider activity provide actionable signals for the upcoming trading session.

30 high priority 20 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — September 24, 2026

The sole contract in this digest is a $237.8 million firm-fixed-price award to M. A. Mortenson Company by the National Institutes of Health (NIH) for design-build construction of a clinical and computational science building in Bethesda, MD. This is a civilian, non-defense award, representing a fully funded, multi-year revenue stream with no options or set-asides. The highest-conviction signal is the full upfront funding and competitive award, indicating strong execution confidence from NIH. A key risk is the firm-fixed-price structure, which transfers cost overrun risk to Mortenson, particularly given the specialized research facility requirements.

1 total filings
· daily

New Federal Contractors — September 24, 2026

The digest covers a single, large civilian contract totaling $237.8 million awarded to M. A. Mortenson Company by the National Institutes of Health (NIH) for a clinical and computational science building in Bethesda, MD. This is a fully funded, firm-fixed-price delivery order with no options, providing multi-year revenue visibility through March 2031. The contract is bullish for Mortenson, signaling strong competitive positioning in specialized research facility construction, but carries medium execution risk due to the fixed-price structure. Key watch items include cost overruns and NIH construction budget trends.

1 total filings
· daily

Significant Contract Modifications ($10M+) — September 24, 2026

This digest covers a single, large civilian contract: a $237.8 million firm-fixed-price award to M. A. Mortenson Company from the National Institutes of Health (NIH) for a clinical and computational science building. The contract is fully funded with no options, providing multi-year revenue visibility through March 2031, but carries execution risk typical of fixed-price construction. As a civilian agency award, it is less exposed to DoD budget volatility but still subject to broader federal construction spending trends. The highest-conviction signal is the full upfront funding, which de-risks the revenue stream for Mortenson. Key watch items include potential cost overruns on the fixed-price structure and NIH budget trends for follow-on awards.

1 total filings
· daily

Contract Deobligations Alert — September 24, 2026

This digest covers a single, large civilian contract: a $237.8 million firm-fixed-price award from the National Institutes of Health (NIH) to M. A. Mortenson Company for a clinical and computational science building. The contract is fully funded with no options, providing multi-year revenue visibility for Mortenson through March 2031. The highest-conviction signal is the bullish revenue stream for a non-defense contractor in the specialized research facility construction sector, though the firm-fixed-price structure carries medium execution risk. The key watch item is monitoring Mortenson's quarterly earnings for revenue recognition and any cost overrun disclosures that could impact profitability.

1 total filings
· daily

Contract Option Exercises — September 24, 2026

This digest covers a single, large civilian contract award: a $237.8 million firm-fixed-price delivery order from the National Institutes of Health (NIH) to M. A. Mortenson Company for the design-build of a clinical and computational science building in Bethesda, MD. With zero defense-related contracts in the period, the investment story is entirely civilian, focused on the stable, long-term capital construction needs of the federal health research apparatus. The highest-conviction signal is the full upfront funding and multi-year (4.3-year) revenue visibility for Mortenson, though the firm-fixed-price structure introduces execution risk on a project of this scale. Key watch items include cost overrun disclosures and the trajectory of NIH construction budgets for potential follow-on awards.

1 total filings
· daily

All HHS Contracts — September 24, 2026

The sole contract in this period is a $237.8 million firm-fixed-price award from the National Institutes of Health to M. A. Mortenson Company for the design-build construction of a clinical and computational science building in Bethesda, MD. This is a civilian (HHS) contract with no defense linkage, representing a fully funded, multi-year revenue stream for Mortenson through March 2031. The highest-conviction signal is the full upfront funding and competitive award, which provides strong revenue visibility but carries execution risk due to the fixed-price structure. Key watch items include cost overruns, change orders, and NIH construction budget trends.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — September 24, 2026

This digest covers a single $237.8 million civilian mega-contract awarded to M. A. Mortenson Company by the National Institutes of Health (NIH) for design-build construction of a clinical and computational science building in Bethesda, MD. The contract is fully funded upfront with no options, providing Mortenson with a low-risk, multi-year revenue stream of approximately $55 million annually through March 2031. As a civilian agency award under full and open competition, it signals stable demand for specialized research facility construction but carries medium execution risk due to its firm-fixed-price structure. The absence of defense contracts in this period highlights a civilian-led procurement environment, with the key watch item being Mortenson's ability to manage cost overruns on this complex project without eroding margins.

1 total filings
· daily

High-Value Federal Grants ($5M+) — September 24, 2026

The sole contract in this period is a $237.8 million firm-fixed-price delivery order from the National Institutes of Health (NIH) to M. A. Mortenson Company for the design-build of a clinical and computational science building in Bethesda, MD. This is a civilian (non-defense) award, representing a fully funded, multi-year project with no options, signaling strong budget commitment from NIH. The contract provides Mortenson with significant revenue visibility of approximately $55.3 million annually through March 2031, but the fixed-price structure introduces execution risk. The highest-conviction signal is the bullish revenue visibility for Mortenson, while the key risk is potential cost overruns on a complex construction project. Investors should monitor Mortenson's earnings for revenue recognition and any change orders that could impact margins.

1 total filings
· daily

General Federal Contracts — September 24, 2026

This digest covers a single, large civilian contract awarded by the Department of Health and Human Services (NIH) to M. A. Mortenson Company worth $237.8 million, with no defense-related content. The award is a firm-fixed-price delivery order for a specialized research facility in Bethesda, MD, signaling a fully funded, multi-year revenue stream for Mortenson through March 2031. The highest-conviction signal is the bullish revenue visibility, though the fixed-price structure introduces medium execution risk. Key watch items include cost overrun disclosures and NIH budget trends for potential follow-on work.

1 total filings
· daily

Nasdaq 100 Stocks SEC Filings — September 24, 2026

The NASDAQ-100 digest this period reveals a bifurcated landscape: consumer-facing giants like Costco continue to deliver robust top-line growth and margin expansion, while Starbucks embarks on a painful but necessary restructuring, slashing its store opening guidance and booking $300M in charges. The most alarming signal comes from the AI infrastructure sector, where CoreWeave's CEO and CFO executed massive insider sales totaling nearly $15M, starkly contrasting with Apple's more modest, plan-driven insider sale. Proxy season is underway for ADP and Lam Research, with annual meetings set for November, offering no immediate financial catalysts but setting the stage for governance votes. The overarching theme is a divergence between resilient consumer demand (Costco) and strategic retrenchment (Starbucks), with a critical red flag in AI/hyperscaler sentiment from insider behavior at CoreWeave.

5 high priority 4 medium 9 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — September 24, 2026

The September 24, 2026, batch of 27 filings reveals a landscape dominated by significant insider stake reductions and activist campaigns, particularly in the small-cap and micro-cap space. A clear pattern emerges of major shareholders monetizing positions, with Oaktree Capital selling a $162.5M block in TORM plc and the CEO of Xanadu Quantum Technologies selling $45M+ in stock. Activist pressure is intensifying at PAINREFORM LTD., where a 5.7% holder is demanding a full board removal, while the newly formed Host Digital Inc. (formerly Healthy Choice Wellness Corp.) sees three separate filings disclosing a combined ~87% insider ownership post-merger, creating a highly concentrated control structure. The withdrawal of People Inc.'s (IAC) acquisition proposal for MGM Resorts, despite retaining a 26.5% stake, signals a shift from active M&A to a 'wait-and-see' strategic review. Overall, the data points to a period of portfolio rebalancing by insiders and activists, with capital flowing out of mature positions and into new, potentially transformative corporate structures.

19 high priority 8 medium 27 total filings
· daily

S&P 500 Financials Sector SEC Filings — September 24, 2026

The S&P 500 Financials sector is showing a bifurcated pattern this week: capital markets activity is robust with Wells Fargo and AIG issuing a combined $7.1B in new debt, signaling confidence in credit markets and a need for liquidity, while insider selling by top executives at Robinhood and major holders at Morgan Stanley and Aflac creates a cautionary undercurrent. The most critical development is Robinhood CEO Vladimir Tenev's $30M stock sale, reducing his holdings to near zero, which is a severe bearish signal for the fintech subsector. On the positive side, MetLife's preliminary Q3 variable investment income of at least $600M implies a strong quarter, though it raises questions about the back-end loaded nature of its annual guidance. Period-over-period comparisons are largely absent from these filings, but the aggregate capital raising activity ($7.1B) suggests a sector-wide preparation for either growth or balance sheet fortification. The overall sentiment is mixed, with debt issuance indicating institutional confidence but insider activity pointing to individual skepticism at the top.

3 high priority 4 medium 7 total filings
· daily

S&P 500 Energy Sector SEC Filings — September 24, 2026

The seven filings from the S&P 500 Energy sector reveal a period of routine corporate governance and insider activity, with no major operational or financial surprises. The dominant theme is the vesting and tax-withholding transactions by five ONEOK executives, which are standard post-vesting procedures and not indicative of bearish sentiment. EOG Resources announced a significant CFO transition, with a 30-year veteran retiring and a new hire from Morgan Stanley, signaling a potential strategic shift. A minor insider purchase by a 10% owner at Texas Pacific Land Corp suggests continued confidence. Overall, the filings show stable insider activity and leadership changes, with no period-over-period financial comparisons or forward-looking guidance to drive immediate investment action. The sector appears to be in a steady state, with management teams focused on routine compliance and succession planning.

7 high priority 7 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — September 24, 2026

The two Consumer Staples filings reveal a bifurcated landscape: Costco's robust Q4 FY2026 results underscore the resilience of warehouse retail with 11.2% net sales growth and strong earnings expansion, while McCormick's insider phantom stock award signals a routine compensation event with no material market implications. Costco's period-over-period comparisons show accelerating revenue growth (10.1% FY vs 11.2% Q4) and margin improvement, though international comparable sales lag, particularly in Canada (5.0% vs 9.4% total). The absence of forward-looking guidance or capital allocation changes in either filing limits catalyst visibility, but Costco's consistent earnings beat and tariff refund benefit provide a positive sentiment anchor for the sector. No portfolio-level patterns emerge across the two filings, but Costco's performance reinforces the defensive growth narrative in consumer staples amid macroeconomic uncertainty.

1 high priority 1 medium 2 total filings
· daily

S&P 500 Industrials Sector SEC Filings — September 24, 2026

Today's filings from the S&P 500 Industrials stream are dominated by two payroll/HR services companies—ADP and Paychex—in an otherwise quiet session. The most significant development is Paychex's Q1 FY26 earnings, which show a mixed picture: revenue grew 5.9% YoY to $1.63B and net income rose 12.0%, but cash flow from operations collapsed 42.5% YoY to $413.5M and cash reserves plummeted 59.9% to $655.9M, signaling potential working capital strain or aggressive capital deployment. ADP's proxy filings are routine governance matters with low materiality, though the board refreshment with two new nominees and the retirement of former CEO Carlos Rodriguez signals a leadership transition. The overarching theme is that while top-line growth remains steady in the payroll/HR space, cash conversion and balance sheet strength are diverging sharply, warranting close monitoring of Paychex's liquidity trajectory.

2 high priority 1 medium 3 total filings
· daily

US Material Events SEC 8-K Filings — September 24, 2026

This batch of 50 filings reveals a market sharply bifurcated between aggressive capital deployment and defensive refinancing. Major themes include a surge in large-scale, strategic M&A and partnerships (Akamai's $11.6B AI deal with Anthropic, Select Water's $700M acquisition, Elmet Group's $124.75M strategic stake) alongside a wave of debt capital markets activity as companies lock in long-term financing (Marriott's $5B revamp, Alexandria's $5B facility, Vistra's $1.5B note offering). A significant number of smaller-cap companies are resorting to dilutive financing (Jaguar Health, Patriot National, Glucotrack) or restructuring debt (DevvStream, Crypto Co), signaling a liquidity crunch in the lower end of the market. Governance changes were routine, but shareholder activism is visible at AMC Entertainment, where four key proposals failed despite overwhelming support, highlighting a structural governance issue. The data shows no uniform period-over-period trends, as most filings lacked financial statements, but the capital allocation patterns are stark: large caps are investing and refinancing, while small caps are fighting for survival.

50 high priority 50 total filings